The global population health management market can be segmented based on component, delivery mode, and end-user. In terms of component, the global population health management has been segmented into software, hardware, and services. The services segment has been further divided into consulting, business intelligence, analytics, and others. The consulting and business intelligence segments dominated the population health management market in 2016, owing to the rising demand for business intelligence tools to analyze the data in the process of decision making from a patient perspective. The software segment is expected to lead the population health management market during the forecast period, with highest CAGR, attributed to the introduction of the Patient Protection & Affordable Care Act (ACA) and encouragement to hospitals by public and private players to take up population health management programs. Based on delivery mode, the global population health management market has been classified as web-based, mobile-based, cloud-based, and others. The web-based segment held the largest share of the population health management market in 2016 due to the continuous efforts being made by governments to reduce health care costs and rapid adoption of private payers to value-based purchasing model. However, the mobile-based segment is anticipated to witness highest CAGR and is expected to account for the largest share of the global population health management market in terms of revenue by 2025. Emergence of big data analytics is a major factor likely to drive the mobile-based market during the forecast period.

Obtain Report Details @
http://www.transparencymarketresearch.com/population-health-management-solutions-market.html

Population health management is characterized as collecting and analyzing the data on segments of patient population and management of that data for specific diseases within that population. It is a model which helps the health care providers and payers to assess the populations they serve across the continuum of care. Population health management is thus a comprehensive approach which requires both analysis and action, and utilized to uncover the gaps in health care for the benefits of patients and physicians. It improves health management outcomes by aligning physicians, coordinating the medical care, and optimizing efficiency as well as revenue. Major factors driving the population health management market are continued pressures to minimize health care costs, rising demand to improve the healthcare services quality, and implementation of value-based payment system. However, lack of trained and efficient professionals, safety of data and its management concerns, and lack of proper systems requiring investment to run the population health management program smoothly are the major restraints of the population health management market.

In terms of end-user, the global population health management market has been segmented into health care providers, health care payers, government organizations, and employer groups. The health care providers segment captured the largest market share in terms of revenue in 2016, attributed to rising incidence of chronic diseases among the population and increasing demand for better and healthy patient quality of life. The health care payers and providers segments are projected to dominate the global population health management market from 2017 to 2025, owing to increasing demand for effective and systematic disease management.

Geographically, the global population health management market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the population health management market in terms of revenue in 2016, attributed to the reforms and investments being made to modernize the health care infrastructure in the U.S. However, the market in Asia Pacific is expected to expand at the highest CAGR during the forecast period, owing to the growing medical tourism in developing countries in Asia and the rapidly expanding health care industry in China and India. North America is anticipated to continue to dominate the market during the forecast period due to the efforts being taken to digitalize the health care system in the region.

Key players in the global population health management market are Allscripts Healthcare Solutions, Inc., Cerner Corporation, Accenture, Conifer Health Solutions, LLC, McKesson Corporation, IBM Corporation, Wellcentive, Inc., and Epic Corporation, Inc., among others.

Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4174

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR Syndicated Research report covers a different sector – such as pharmaceuticals, chemical, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, our syndicated reports thrive to provide clients to serve their overall research requirement.

Name: Rohit Bhisey
Organization: Transparency Market Research
Website: http://www.transparencymarketresearch.com/

ReleaseID: 8108

The global market for menopausal hot flashes is a moderately fragmented market, in which the top eight players collectively held a share of more than 50% in 2014, states a new research study by Transparency Market Research (TMR). Novartis AG and Pfizer Inc., the top two vendors, which accounted for nearly 30% of this market in 2014, are expected to maintain their stronghold over the next few years. Pfizer is expected to gain from its robust presence across North America while Novartis will benefit from its wide-ranging product portfolio for the treatment of menopausal hot flashes in the years to come, notes the study.

According to this report, the total opportunity in the global Menopausal Hot Flashes Market was US$3.77 bn in 2014. Researchers predict this market to rise at a CAGR of 3.70% during the period from 2015 to 2023 and increase to US$5.28 bn by the end of the forecast period.

Demand for Hormonal Products to Remain Strong

According to the report, hormonal products have been witnessing an overwhelming demand across the world, as people prefer hormone replacement therapies for the treatment of menopausal hot flashes. In 2014, the hormonal products segment held a staggering 95% of the overall market and is anticipated to continue on the same track over the next few years. Non-hormonal products, however, are expected to gain momentum in the near future, since the awareness regarding the harmful effects hormonal therapies on women’s health is increasing considerably.

Inquire for a Sample Copy of Report – http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2856

In terms of the geography, the global market for menopausal hot flashes is led by North America, reports the study. The increasing incidence of menopausal vasomotor symptoms in the female population in this region is the key factor behind the growth of this market in North America. In 2014, the regional market acquired a share of 66% in the overall market and is projected to remain on the top over the period of the forecast.

Amongst others, the menstrual hot flashes market in Asia Pacific is anticipated to outshine in terms of value and volume in the next few years due to the rising awareness pertaining to menopause-related health issues and the increasing disposable income of consumers in this region.

Swift Approval of New Treatments to Drive Growth

“The global market for menopausal hot flashes is gaining substantial impetus from the rising instances of night sweats caused by menopause and vasomotor symptoms, commonly known as, hot flashes,” says the author of this study. The increasing number of favorable initiatives commenced by several governments and private healthcare institutes to raise the awareness regarding women’s health among people across the world is another important factor that is boosting this market.

Going forward, the speedy approval of new treatments is expected to create new streams for revenue generation for market players in the near future. However, the increasing availability of alternative therapies at a much cheaper rate may limit the growth of this market over the forecast period, states the resesrch report.

Read Report with Complete TOC – http://www.transparencymarketresearch.com/menopausal-hot-flashes.html

Name: Rohit Bhisey
Organization: Transparency Market Research

ReleaseID: 8106

Non-vascular Stents are the special medical tubular devices which are used to relieve the luminal obstructions and strictures caused in different parts of body such as gastrointestinal tract, tracheobronchial tract and urinary tract. These are also used to hold open obstructed lumens during surgery by facilitating the free flow of body fluids and other contents. Non-vascular stents are made of metallic material; most commonly nitinol alloys and non-metallic synthetic polymers such as resins, polyurethane, and silicone materials. Metallic stents are available with the fully covered, partially covered and uncovered stents. Currently, Self-Expanding Metallic Stents (SEMS), are most commonly used for the palliation of malignant strictures and Self Expanding Plastic Stents (SEPS) are used for treatment of benign conditions also in some cases for palliation of malignant condition. Non-vascular stents are broadly classified into three sub segments: Pulmonology stents, Urology Stents, and Gastroenterology stents. These non-vascular stents are required by the hospitals, ambulatory surgical centers, academic medical institutions, long term palliative care centers, and clinical research organizations for research purposes.

According to the report, global Non-Vascular Stents Market was valued at US$ 475.0 Mn in 2016 and is projected to expand at a CAGR of 5.0% from 2017 to 2025 to reach US$ 730.5 Mn by 2025. This report offers a thorough understanding of Non-vascular Stents market across the globe its key trends, drivers, restraints, and opportunities.

Inquire for a sample Copy of Report – http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=27980

The non-vascular stents are primarily used for relieving the luminal obstructions caused due to benign as well as malignant conditions in different body parts such as ureteral tract, gastrointestinal tract, biliary and pancreatic tract, and airway tract. There has been continuous increase in gastrointestinal cancer patients worldwide including biliary and pancreatic cancer patients leading to luminal obstruction in gastrointestinal tract. Also kidney stone disease and benign prostatic hyperplasia in elder population is found to be one of the key causes of ureteral obstructions worldwide. The rapid increase in chronic obstructive pulmonary disease caused due to lung cancer and tracheobronchial malacia is observed globally. The increasing incidences of cancerous diseases leading to luminal obstructions is projected to boost the demand for non-vascular stents during forecast period 2017-2025. The technological development in stent designs, materials and minimally invasive stenting procedures using endoscopes minimizes the surgical complications etc. factors also contributes to boost the demand for non-vascular stents. On the other side, the alternative treatment options for relieving luminal strictures, high cost of metallic stents is likely to restrain the growth of non-vascular stents during forecast period.

The global non-vascular stents market has been segmented into four segments on the basis of product type, material, end-user, and geography. By product type, these are classified into pulmonology stents, urology stents, and gastroenterology stents. The gastroenterology stents are further sub-segmented into enteral stents and biliary and pancreatic stents. Out of these, the gastroenterology stents accounts for largest market share in non-vascular stents market and is projected to dominate the market share over forecast period. The biliary and pancreatic stents market is projected to hold largest market share in gastroenterology stents. High prevalence and incidence rates of gallstone disease in developed countries is projected to be key driving factor for the biliary and pancreatic stents. Also the high prevalence of colorectal and esophagus cancer patients worldwide would generate the demand for gastrointestinal stents over forecast period. The technological developments in stent designs, material composition and novel stent deployment techniques such as endoscopic ultrasound guided (EUS) stenting procedures is also projected to boost the demand for GI stents. Worldwide growing number of chronic obstructive pulmonary disease (COPD) patients due to lung cancer, tracheobronchial malacia, smoking, and exposure to harmful chemical is projected to drive the demand for pulmonology stents market in near future. The urology stents market is projected to expand at exponential growth rate over forecast period owing to increasing number of kidney calculi patients, and end-stage renal disease patients worldwide. A common trend of benign prostatic hyperplasia in elderly demographics is observed across the globe which is also one of the key driving factors for the ureteral stents during forecast period. This segment is projected to grow at CAGR of 6.9 % form 2017-2025, and is likely to gain its market share by the end of 2025. The ureteral stents are most commonly made of silicone and polyurethane material owing to high biocompatibility, radiopacity and are visible under ultrasound.

The End-user for non-vascular stents includes hospitals, ambulatory surgical centers and medical research institutes. The hospitals segment dominated the market share in 2016 and is projected to continue to hold largest market share by the end of 2025. The growth of hospital segment is attributed to increasing number of patients requiring long term treatment of high grade structures and supportive treatment facilities for the related disease. Also high healthcare expenditure per capita and well established healthcare infrastructure in developed countries would propel the hospitals segments business during forecast period. Ambulatory surgical centers is projected to grow at highest CAGR and is likely to gain its market share by the end of 2025. Increasing preference for minimally invasive procedures by both patients as well as doctors owing to shorter duration of stenting procedures and cost effectiveness is the key driving factor for the growth of ambulatory surgical centers. The other end-user accounts for small share of global non-vascular stents market and is likely to maintain steady growth rate during forecast period.

Geographically, the global non-vascular stents market is segmented into five regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America dominated the market and is anticipated to gain its market share by the end of 2025. The growth of North America non-vascular stents market is attributed to well established healthcare infrastructure, high healthcare expenditure per capita, high incidence rates of obstructive diseased patients and favorable medical reimbursement policies by government as well as private players. Followed by North America, Europe is second leading contributor of global non-vascular stents market. Increasing number of hospitals, and ambulatory surgical centers, growing number of patients with obstructive disease would drive the growth of Europe non-vascular stents market. Asia pacific region is projected to expand at exponential growth rate owing to increasing cancerous patients leading to high grade strictures, emerging economies in countries like China and India, increased healthcare budgets by governments and increasing number of hospitals and day care surgery centers.

Major companies competing in the non-vascular stents market, and profiled in the report include Boston Scientific Corporation, C. R. Bard, Inc., Taewoong Medical Co., Ltd., Cook Group Incorporated, Abbott Laboratories, Olympus Corporation, Merit Medical Systems, Inc., ELLA – CS, s.r.o., Medi-Globe Corporation, M.I.TECH, Allium Medical Solutions Ltd., CONMED Corporation.

Read Report with Complete TOC – http://www.transparencymarketresearch.com/non-vascular-stents-market.html

Name: Rohit Bhisey
Organization: Transparency Market Research

ReleaseID: 8105

Albumin is a water soluble globular protein, which is produced in the liver, and contributes 50% of blood plasma proteins. It plays an important role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Commonly used serum albumins are human serum albumins and bovine serum albumins. With technological development, recombinant albumins are produced using recombinant rice plants, recombinant yeast species, and other recombinant cell lines. Human serum albumin is commonly used as blood volumizer in rare diseases, burns, shocks, certain liver conditions, and other blood loss trauma and surgeries. Recombinant albumin has found its application in areas such as diagnostics as binding ligands, excipients for drug formulations, and other life sciences procedures such as blotting. Bovine serum albumin is widely used as a component of cell culture media and other procedures in life sciences.

According to the report, global Albumin Market was valued at US$ 4,802.2 Mn in 2016 and is projected to expand at a CAGR of 9.2% from 2017 to 2025 to reach US$ 10,358.8 Mn by 2025. This report offers a thorough understanding of albumin market across the globe its key trends, drivers, restraints, and opportunities.

Inquire for a Sample Copy of Report – http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3984

Human Serum Albumin is largely used as blood volumizer for burns, shocks, certain liver diseases, chronic blood conditions and during surgeries and trauma to compensate blood loss. With rise in prevalence of these conditions across the globe, global albumin market is projected to expand. With growing usage of recombinant albumin in life sciences applications and as excipient in drug formulations and vaccine production there is high demand for recombinant albumin production which in turn is likely to propel the global albumin market. Plasma fractionation and processing incurs significant cost and expertise which restricts entry of new players in this market. Moreover, it requires expert staff to handle the operations as plasma processing attracts stringent laws and regulations. Also scarcity of raw plasma for fractionation is another major concern among the industry players. This has limited the entry for new players in this market, and restrains the growth of albumin market across the globe.

Based on the product type, global albumin market is segmented into human serum albumin (HSA ) which is derivative of human plasma, bovine serum albumin (BSA) derived from fetal bovine serum, and recombinant albumin produced using recombinant yeast, rice and other culture sources. Among these these human serum albumin segment contributed largest share in global albumin market in 2016. This segment is expected to grow at CAGR of 9.2% during the forecast period from 2017 to 2025. Human serum albumin is widely used as a blood volumizer in conditions such as burns, shocks, rare diseases, etc. Huge demand for blood volumizer from emerging markets like China, India, and Brazil is expected to fuel this growth over the forecast period. The recombinant albumin segment is projected to expand at a CAGR of 6.0% from 2017 to 2025. rAlbumin is widely used in drug formulation, drug delivery, diagnostics and in many of the life sciences procedures. Bovine serum albumin market is expected to grow at CAGR of 2.6% during forecast period. BSA finds application as a major component of cell and microbial culture media. High demand of recombinant albumin and bovine serum albumin as an excipient in drug delivery and vaccine production is expected to drive demand for these segments from 2017 to 2025.

By application the global albumin market is segmented into blood volumizer, drug formulation and vaccine, life sciences, and others. Human serum albumin is widely used as blood volumizer and this segment accounted to largest share of global albumin market in 2016. Blood volumizer application segment is expected to grow at CAGR of 10.3 % and is expected to gain market share during forecast period from 2017 to 2025. Rise in prevalence of its indicative conditions such as burns, shocks, trauma, liver diseases and rare diseases across the globe are expected to be drivers for growth of the segment. Drug formulation and vaccine is second leading application segment. This segment is expected to grow at CAGR of 6.1 % for forecast period from 2017 to 2025. Albumin is increasingly used as excipients in drug delivery, and production of vaccines to stabilize the active drug ingredient owing to its features such as protein stabilizer, reducing drug or protein denaturation and low immunogenicity in patient.

Geographically the global albumin market is segmented in to North America, Europe, Asia Pacific, Latin America and Middle East 7 Africa. Asia pacific region dominated the global albumin market and is projected to expand at CAGR of 11.5 % over forecast period from 2017 to 2025. Emerging markets such as India and China are expected to fuel the growth of the albumin market in Asia Pacific. Growth of the market is attributed to large geriatric population and increase in prevalence of rare diseases, burns, and surgeries. Both North America and Europe are projected to lose their market share during given forecasted period owing to rise in preference for albumin alternatives and ambiguity in use of albumin as proven blood volumizer. However, other applications of albumin in drug development and vaccine production are expected to compensate for the decline during the forecast period in this region.

Major companies competing in the albumin market, and profiled in the report include CSL Behring LLC, Grifols International, S.A., Octapharma AG, Kedrion S.p.A., Baxalta Inc. (Shire plc), Octapharma AG, InVitria, Kedrion S.p.A., Mitsubishi Tanabe Pharma Corporation, Albumedix A/S (Novozyme A/S), Sigma-Aldrich Co. LLC. (Merck KGaA), Thermo Fisher Scientific, Inc., HiMedia Laboratories Pvt. Ltd., Medxbio Pte. Ltd.

Read Report with Complete TOC – http://www.transparencymarketresearch.com/albumin-market.html

Name: Rohit Bhisey
Organization: Transparency Market Research

ReleaseID: 8104

Led by several established players, such as America Cell Biobank Inc., CrioCenter, Banco de Cordon Umbilical (BCU), and Redcord S.A., the cord blood banking services market in Latin America has been demonstrating a highly competitive and fragmented business landscape, states a research study by Transparency Market Research (TMR). The market is characterized by various rules and policies that vary from country to country.

The market players are relying heavily on technical advancements for expansion in their businesses. CrioCenter, CordVida, Cellpreserve, CordCell, Redcord S.A., Cordón de Vida, Banco de Células Stem, and Células Madre C.A. are the other prominent cord blood banking service providers across Latin America, the report mentions.

the Latin America market for cord blood banking services was worth US$196.9 mn in 2014. Researchers project the market to proliferate at a CAGR of 9.40% over the period from 2015 to 2023 and attain a value of US$445.4 mn by the end of the forecast period.

Inquire for a Sample Copy of Report – http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=8413

Public Cord Blood Banking Services to Report Dominance

Currently, cord blood banking services are being discretely provided in the public and the private sectors, resulting in two types of storages, public and private, in this Latin American market. With continual funds from the governments, non-government organizations, and research societies, the public cord blood banking services segment has registered its dominance in this market. Analysts expect the scenario to remain so over the forecast period.

The research report also presents a comprehensive assessment of the Latin America market for cord blood banking services on the basis of its geographical bifurcation. Brazil, Columbia, Mexico, Argentina, and the Rest of Latin America have been considered as the main geographical segments of this regional market in this study. Brazil, Mexico, and Columbia have surfaced as the leading domestic markets for cord blood banking services in this region and are focusing aggressively on expanding the network of cord blood banks in Latin America.

Increasing Research Activities in Stem Cell Therapies to Boost Growth

“The market for cord blood banking services in Latin America has been gaining significant impetus from the advancements in the stem cell therapy research, thanks to the increasing infrastructural and technological progression in this region,” says a TMR analyst.

The high incidence rate of genetic disorders and quick and better treatment of such diseases, owing to the easy availability of advanced diagnostic services that provide accurate results are also supporting the growth of the Latin America cord blood banking services. However, the high charges for cord blood banking services and the common opinion among medical professionals about the less possibility of the usage of stored cord blood may limit the adoption of these services in a number of Latin American countries, such as Mexico, Brazil, Peru, and Argentina, reflecting negatively on the overall market, states the research report.

Read Report with Complete TOC – http://www.transparencymarketresearch.com/latam-cord-blood-banking-services-market.html

Name: Rohit Bhisey
Organization: Transparency Market Research

ReleaseID: 8101

Usage of technology in the healthcare industry is empowering healthcare to save more lives and help people to recover from diseases more comfortably. Technically advanced equipment are used for every treatment and this is helping the healthcare informatics and patient monitoring market to grow globally. This market seems to rise exponentially in India due to the rising demand for better medical resources. According to Transparency Market Research, the healthcare informatics and patient monitoring market in India is expected to rise at a CAGR of 16.3% for the period 2017-2025 to attain a value of US$560.9 mn by 2025.

The informatics and patient monitoring market in India can be demographically divided into two segments – rural and metropolitan. Among these, metropolitan hospitals & healthcare facilities dominate the rural hospitals & healthcare facilities with a vast difference. On account of this, for the year of 2014 urban hospitals & healthcare facilities accounted for 88% of the total market.

Inquire for a Sample Copy of Report – http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26276

The increasing number of hospital beds in metropolises and cities and growing occurrences of fatal disorders in urban areas have aided this segment to gather the major share of the market. One of the other major factors for this segment’s dominant position is the escalating occurrence of cardiovascular and respiratory diseases in these regions due to various types of pollutions.

The escalating geriatric population has augmented the incidence of chronic diseases in India. This situation has created increased demand for advanced healthcare devices and equipment.

Southern India is quickly adopting technologically advanced patient monitors and latest medicinal technologies because of firm support from the government. The market for South India stood at US$56.81 mn in 2015 that formed a share of 39.0% of the India healthcare informatics and patient monitoring market.

Taking inspiration from the healthcare facilities provided in South India, state governments of other states are starting programs to improve the healthcare infrastructure in their states. This will further help the healthcare informatics and patient monitoring market to grow in India.

In addition, many startups are emerging in India with an aim to provide cheaper and innovative healthcare solutions to the common people. Big companies are trying to reform the healthcare system by introducing technologically advanced equipment as well.

For instance, Philips has introduced advanced healthcare solutions that showcase the future of healthcare in India. They have introduced advanced systems such as automatic charting and flow sheets of patients in critical care, eICU solutions, virtual ICUs, wireless networking monitoring systems, and systems that will transmit details about patient from the ambulance to the hospital. Furthermore, Philips has successfully installed these new solutions in hospitals of Mumbai and Pune, and is planning to install them in various hospitals across the country. These collective efforts from governments, startups, and established businesses ensure the bright future for healthcare informatics and patient monitoring market.

Read Report with Complete TOC – http://www.transparencymarketresearch.com/healthcare-informatics-patient-monitoring-market.html

Name: Rohit Bhisey
Organization: Transparency Market Research

ReleaseID: 8103

Some of the prominent players operating in the global geriatric medicines market are Sanofi S.A., Pfizer, Inc., Novartis International AG, Merck & Company Inc., GlaxoSmithKline plc, Eli Lilly and Company, Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Ko. KG, Abbott Laboratories, Inc., and AstraZeneca plc. Several players are capitalizing on emerging opportunities in a number of developing nations as the governments are making substantial investments in providing geriatric medicine and palliative care, observes Transparency Market Research (TMR).

The global market for geriatric medicines stood at US$ 504.7 bn in 2014 and is projected to expand at a CAGR of 7.3 % during 2015–2023. Rising at this pace, the opportunities in the market is anticipated to reach US$ 948.0 bn by the end of 2023.

Asia Pacific to Provide Lucrative Growth Avenues in Coming Years

Regionally, the global geriatric medicines market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. Of these, the Asia Pacific market is expected to rise at the substantial CAGR over the forecast period. The growth of the regional market is expected to be fueled by the increasing prevalence of medical conditions and diseases affecting the aged people and substantial government initiatives in providing quality geriatric care through care units.

Inquire for a Sample Copy of Report – http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2445

Based on the disease condition, the geriatric medicines market is segmented into arthritis, cardiovascular, neurological, osteoporosis, respiratory, and cancer. Among these, the cardiovascular segment held the major revenue share in 2014 and is projected to rise at the fastest CAGR over the forecast period. The dominance of the segment is attributed to the rising prominence of cardiovascular conditions affecting the elderly people needing geriatric care and the mounting concerns related to cardiac attacks.

Governments’ Push for Quality Geriatric Care Bodes Well for Market

The global geriatric medicines market is primarily driven the general rise in the elderly populations in various regions, particularly in developing and developed nations. The growing prevalence of adults aged over 65 years that are affected by a variety of chronic conditions and the rising incidence of diseases such as neurological disorders, cancer, rheumatoid arthritis, and cardiovascular disorder are the key factors boosting the geriatric medicines market. A large number of aged people reliant on polypharmacy are prone to the side-effects due to the interactions of the different medications. This has propelled the demand for geriatric care, thereby catalyzing the geriatric medicines market.

The increasing prevalence medication-related problems among older adults and the pressing need for palliative care are the seminal factors boosting the geriatric market. Furthermore, in recent years, the concerted efforts by governments in providing quality geriatric care in a number of emerging countries and the significant investments made by them in opening geriatric care units have accentuated the market. The rising prevalence of aged people suffering from different chronic conditions has fueled the demand for analgesics among the elderly population, thereby stimulating the uptake of geriatric medicines. The increasing prevalence of various cardiovascular conditions has triggered the incidence of heart attacks, thereby fueling the demand for geriatric medicines.

However, the lack of awareness about the availability of geriatric care among elderly patients in emerging nations is a crucial factor likely to impede the market to an extent. On the other hand, constant advances in healthcare infrastructure in several nations in developing and developed regions is expected to open up exciting opportunities for market players.

Read Report with Complete TOC – http://www.transparencymarketresearch.com/geriatric-medicine-market.html

Name: Rohit Bhisey
Organization: Transparency Market Research

ReleaseID: 8102

The nature of the global cubic boron nitrates market is highly consolidated, states Transparency Market Research (TMR) in a research report. The leading three companies collectively held a share of over 48% in the market in 2015. It has been projected that the scenario will be almost the constant in the years ahead. The leading players such as Saint-Gobain, Showa Denko K.K., and 3M are expected to display backward integration towards the hexahedron boron nitrates market. As a result of this the competitive landscape of the market is expected to be comparatively moderate. At present, the key strategy that has been adopted by the leading market players is product advancement for developing their business and keeping pace with the changing scenario along with increasing their consumer base.

According to a TMR analyst, “The global market for cubic boron nitrates is anticipated to rise at a 7.10% CAGR from 2016 to 2024. In 2015, the market was worth US$531.3 mn and is expected to rise to a valuation of US$978.9 mn by 2024.”

Browse Market Research Report @ http://www.transparencymarketresearch.com/cubic-boron-nitrates-market.html

Inserts to Remain in Demand Strongly

Powder, mesh, wheels, and inserts are the principle items accessible in the worldwide market for cubic boron nitrates. Amongst these, the demand for inserts is greater than others and is expected to remain so in the following couple of years. The expanding use of supplements in the metal preparing industry, inferable from the rising necessity of procedures, for instance, cutting, crushing, and completing for items in the aerospace, medical, and the automotive segments is relied upon to support the demand for inserts over the world sooner rather than later. Because of the expanding usage of inserts in cutting and granulating applications, the demand for wheels is probably going to decrease discernibly throughout the following couple of years.

Get accurate market forecast and analysis on the Cubic Boron Nitrates Market. Request a sample to stay abreast on the key trends impacting this market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1917

Region-wise, Asia Pacific dominated the global cubic boron nitrates with a share of 35% in the same year. Researchers anticipate that this territorial market will stay driving throughout the forecast period, because of the presence of a substantial number of market players and the broad interest for cubic boron nitrates in different Asian economies, Japan, India, and China.

Proliferating Awareness to Accelerate Demand of Cubic Boron Nitrates

The expanding mindfulness with respect to the advantages of cubic boron nitrates over other hard materials utilized for different modern procedures, for instance, cutting, pounding, boring, and exhausting, is having the extreme effect on the development of the worldwide market for cubic boron nitrates. Precious stone is said to be the hardest material used for these procedures however it additionally has different mechanical impediments, which gives a cubic boron nitrates an edge over it, considering decidedly the interest for the previous over the world.

Right now, the market looks flourishing and brimming with circumstances. Be that as it may, the high cost related with the creation procedures may stop this market from developing consistently in the years ahead.

The global cubic boron nitrates market has been segmented as follows:

By Product

–Inserts
–Wheels
–Mesh
–Powder

By Application

–Raw Abrasives
–Coatings
–Cutting & Grinding
–Lapping & Polishing
Others

The study presented here is based on a report by Transparency Market Research (TMR), titled, “Cubic Boron Nitrates Market (Product – Inserts, Wheels, Mesh, and Powder; Application – Raw Abrasives, Coatings, Cutting & Grinding, and Lapping & Polishing) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024.”

Name: Rohit Bhisey
Organization: Transparency Market Research
Website: http://www.transparencymarketresearch.com/cubic-boron-nitrates-market.html

ReleaseID: 8097

Expanding their global footprint and signing strategic cross-border contracts is expected to be the mainstay of companies aiming for global growth in the produced water treatment systems market, finds Transparency Market Research in a new study. Entities such as Schlumberger Water Services, Alderley Plc, and Siemens Water Technology are actively pursuing the development of tertiary patented products to steal a march on the competition. These initiatives will eventually lead to better service and product differentiation, prompting smaller companies to follow suit.

Obtain Report Details @: http://www.transparencymarketresearch.com/produced-water-treatment-market.html

TMR’s projections show that by 2020, produced water volumes will surpass the 340-bn barrel mark. This in indicative of a massive opportunity for companies offering produced water treatment equipment and services.

With Produced Water Reinjection Becoming Customary, Investments in Produced Water Treatment Systems to Rise

Across the world, it is now common practice to reinject produced water given the stringent government regulations at play and the overall scarcity of water. This trend is creating hitherto unexplored opportunities for companies in the produced water treatment systems market. In 2014, while 68% of the 201.4 bn barrels of produced water generated worldwide from oil and gas wells was disposed of, the rest was treated and injected back into oilfields at onshore and offshore locations.

This trend is expected led to a sizeable increase in produced water volume worldwide, reaching 340 bn barrels by 2020. At 23% from 2014 through 2020, offshore reinjection is expected to exhibit the fastest CAGR and will be followed by onshore reinjection.

Besides this high-impact driver, factors such as the rising ratio of oil-to-produced water and an inclination toward unconventional oil exploration are driving investments in produced water treatment systems, observes TMR.

Opportunity for Produced Water Treatment Systems to Touch US$2.6 Bn by 2020 in North America

Produced water treatment systems are expected to account for a market worth US$2.6 bn in North America by 2020. North America is also the clear leader in the global produced water treatment systems market. With crude oil production in North America projected to rise steadily through 2020, the demand for produced water treatment systems in the region is projected to remain strong.

Make an Enquiry @: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3957

With Asia Pacific and Europe trailing North America, the two regions collectively comprised 43% of the global produced water treatment systems market in 2014. The demand for produced water treatment systems in Latin America is expected to grow substantially through the forecasting horizon.

Aging Oil Wells Act as Spur to Development of Highly Efficiency Products and Services

The types of produced water treatment systems can be broadly classified into primary, secondary, and tertiary. Of these, secondary systems generated about 38.6% of the total market revenue in 2012 given the pressing need to cut oil content in produced water.

“However, the growing number of tertiary systems-especially the patented offerings combining the benefits of primary and secondary treatment systems as a bundled or packaged service-will witness strong adoption in the near future. So much so, that securing patents on innovative tertiary systems will lend players a strong edge over their counterparts,” says a TMR analyst. This will consequently lead to tertiary treatment systems displaying a 9.1% CAGR from 2014 and 2020 – the highest among all types of produced water treatment systems.

Produced water treatment systems represented a global market with a valuation of US$3.78 bn in 2012, which will rise to US$6.16 bn by 2020 at a CAGR of 6.1% between 2014 and 2020.

This analysis is based on a report, titled, ‘Produced Water Treatment Systems Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2012 -2020,’ published by Transparency Market Research.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Name: Rohit Bhisey
Organization: Transparency Market Research
Website: http://www.transparencymarketresearch.com/produced-water-treatment-market.html

ReleaseID: 8095

An electrical enclosure is a cabinet which contains various electrical and electronic components. It serves two purposes: protecting the user from electrical shock and safeguarding the parts it covers from external damage. Electrical enclosures are designed to be functional as well as provide aesthetic value. They may also need to exhibit favorable properties with regards to electromagnetic interference, power dissipation, and electrical breakdown. The requirements of electrical enclosures are governed by various national regulatory standards. Stringent regulations are applicable to those used in hazardous areas facing fire or explosion risks, particularly applicable to locations such as coal mines and chemical plants where potential risks include flammable gases, combustible dust, and other volatile vapors or particles. Areas prone to lightning strikes or floods may also warrant use of special types of electrical enclosures.

Obtain Report Details @: http://www.transparencymarketresearch.com/electric-enclosures-market.html

Electrical enclosures protect electrical equipment such as power generators, transformers, and various telecommunication devices and contain electrical components such as knobs, switches, and displays. They are available in various sizes; although broadly, those used for industrial applications are larger than those used in residential areas. This market can be segmented into two groups: enclosures used in the power generation process and those used for transmission & distribution (T&D). This market can also be segmented by the type of material used to manufacture the enclosure into the following categories: plastics, plastic composites, metals, and metal alloys. Plastics typically used for electrical enclosures include acrylonitrile butadiene styrene (ABS), polycarbonate, and styrenic polymers, which can also be reinforced with glass or carbon fibers to increase their mechanical and temperature resistance. PVC was commonly employed for this purpose but its usage has been discouraged as it does not meet modern standards. Among metals and alloys, stainless steel, carbon steel, and aluminum find wide usage. Metal enclosures are sturdier, durable, and offer better protection to environmental elements but are also costlier and difficult to mold compared to plastic enclosures.

Increasing demand for energy and electricity is driving the global electrical enclosures market. China is likely to be a lucrative market due to the rapid industrialization in this country. Expansion of the electrical enclosures market in developed countries in Europe & North America is projected to be moderate (as power infrastructure is already well-developed in these regions) and driven by the installation of power stations running on renewable sources of energy such as solar and wind energy. The need to upgrade the power infrastructure in emerging countries is likely to propel the market for electrical enclosures in the near future. India, Indonesia, and Nigeria are estimated to invest substantially in the utilities sector in the next decade as several parts in these countries do not have access to reliable sources of electricity. The use of better quality materials to manufacture electrical enclosures is also anticipated to become prevalent in these countries with low-cost materials such as PVC expected to be phased out. Demand for good quality electrical enclosures is high in the oil & gas industry. Other major end-users of this market include the power generation, water & wastewater, and mining industries.

Fill the form for an exclusive sample of this report @: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22292

The global electrical enclosures market is highly competitive and fragmented with the presence of a few prominent companies and a high number of smaller players in the unorganized sector. Key players in this market are Eaton Corporation, ABB Ltd, Rittal GmbH & Co. KG, Schneider Electric SE, Hubbell, Inc., Emerson Electric Company, Legrand, Eldon Holding AB, Pentair Plc., and AZZ Inc.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Name: Rohit Bhisey
Organization: Transparency Market Research
Website: http://www.transparencymarketresearch.com/electric-enclosures-market.html

ReleaseID: 8100